Ann Pediatr Endocrinol Metab.  2022 Sep;27(3):192-200. 10.6065/apem.2142168.084.

Predictors of associated and multiple autoimmunity in children and adolescents with type 1 diabetes mellitus

• Kakleas K
• Kossyva L
• Korona A
• Kafassi N
• Karanasios S
• Karavanaki K

• KMID: 2533338
• DOI: http://doi.org/10.6065/apem.2142168.084

Abstract

Purpose
Type 1 diabetes mellitus (T1DM) is an autoimmune condition characterised by the presence of antipancreatic antibodies. The autoimmune process is also directed against other organs, most frequently against the thyroid gland, intestinal mucosa, and gastric parietal cells.
Methods
Our investigation included 121 children with T1DM with a mean age±standard deviation of 11.99±4.63 years (range, 2.0–20.0 years). We explored the frequency of associated autoimmunity; the presence of predictive factors such as current age, sex, and severity at diabetes diagnosis; T1DM duration; and family history of autoimmunity.
Results
Associated autoimmunity was present in 28.9% of T1DM patients. Children with associated autoimmunity were older at diabetes diagnosis (p=0.009) and had a longer diabetes duration compared to children without associated autoimmunity (p=0.044). Adolescents aged 12–20 years had a statistically significant higher chance of developing thyroid autoimmunity compared to children aged 1–5 years (p=0.019). Multiple autoimmunity (MA), T1DM, and 2 or more autoimmune diseases were present in 5.8% of the study population. All children with MA presented with ketoacidosis at diabetes diagnosis and had a higher percentage of familial autoimmunity (p=0.042). The familial autoimmunity of these patients most frequently affected ≥3 relatives (p=0.026) and was more frequently diagnosed before 5 years of age (p=not significant).
Conclusion
Associated autoimmunity was present in almost one-third of T1DM patients. Significant associations with associated autoimmunity were longer diabetes duration, female sex, older age at diabetes diagnosis, and glutamic acid decarboxylase positivity. Predictors of MA were age <5 years at T1DM diagnosis, the presence of diabetic ketoacidosis at diagnosis, and a significant family history of autoimmunity.

Keyword

Type 1 diabetes mellitus; Child; Associated autoimmunity; Multiple autoimmunity; Predictors

Reference

References

1. Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018; 19 Suppl 27(Suppl 27):7–19.

2. Barker JM. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006; 91:1210–7.

3. Husebye ES, Anderson MS, Kämpe O. Autoimmune polyendocrine syndromes. N Engl J Med. 2018; 378:1132–41.

4. Kordonouri O, Klingensmith G, Knip M, Holl RW, Aanstoot HJ, Menon PS, et al. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetes-associated conditions in children and adolescents. Pediatr Diabetes. 2014; 15 Suppl 20:270–8.

5. Wägner AM, Santana A, Herńndez M, Wiebe JC, Nóvoa J, Mauricio D. Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes Metab Res Rev. 2011; 27:493–8.

6. Kawasaki E, Maruyama T, Imagawa A, Awata T, Ikegami H, Uchigata Y, et al. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus. J Diabetes Investig. 2014; 5:115–8.

7. Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD Clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018; 19 Suppl 27:155–77.

8. Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010; 6:270–7.

9. De Block CE, de LeeuwIH, Vertommen JJ, Rooman RP, Du CajuMV, Van Campehout CM, et al. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol. 2001; 126:236–41.

10. Abraham MB, Jones TW, Naranjo D, Karges B, Oduwole A, Rauschmann M, et al. ISPAD clinical practice consensus guidelines 2018: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatric Diabetes. 2018; 19 Suppl 27:178–92.

11. Hughes JW, Riddlesworth TD, DiMeglio LA, Miller KM, Rickels MR, McGill JB, et al. Autoimmune diseases in children and adults with type 1 diabetes from the T1D exchange clinic registry. J Clin Endocrinol Metab. 2016; 101:4931–7.

12. Głowińska-Olszewska B, Michalak J, Łuczyński W, Del Pilar Larosa M, Chen S, Furmaniak J, et al. Organ-specific autoimmunity in relation to clinical characteristics in children with long-lasting type 1 diabetes. J Pediatr Endocrinol Metab. 2016; 29:647–56.

13. Jung ES, Han DK, Yang EM, Kim MS, Lee DY, Kim CJ. Thyroid autoimmunity in children and adolescents with newly diagnosed type 1 diabetes mellitus. Ann Pediatr Endocrinol Metab. 2014; 19:76–9.

14. Hwang GB, Yoon JS, Park KJ, Lee HS, Hwang JS. Prevalence of autoimmune thyroiditis in patients with type 1 diabetes: a long-term follow-up study. Ann Pediatr Endocrinol Metab. 2018; 23:33–7.

15. Kakleas K, Paschali E, Kefalas N, Fotinou A, Kanariou M, Karayianni C, et al. Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Ups J Med Sci. 2009; 114:214–20.

16. Borzutzky A, Seiltgens C, Iruretagoyena M, Cristi F, Ponce MJ, Melendez P, et al. A126: clusters of autoimmune diseases in children and the role of PTPN22 C1858T Gene polymorphism in pediatric polyautoimmunity. Arthritis Rheumatol. 2014; 66:S164–5.

17. Kakleas K, Soldatou A, Karachaliou F, Karavanaki K. Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmun Rev. 2015; 14:781–97.

18. Taneja V. Sex hormones determine immune response. Front Immunol. 2018; 9:1931.

19. Jonsdottir B, Larsson C, Carlsson A, Forsander G, Ivarsson SA, Lernmark Å, et al. Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis. J Clin Endocrinol Metab. 2017; 102:1277–85.

20. Sahin Y. Celiac disease in children: a review of the literature. World J Clin Pediatr. 2021; 10:53–71.

21. Kylökäs A, Kaukinen K, Huhtala H, Collin P, Mäki M, Kurppa K. Type 1 and type 2 diabetes in celiac disease: prevalence and effect on clinical and histological presentation. BMC Gastroenterol. 2016; 16:76.

22. Salardi S, Volta U, Zucchini S, Fiorini E, Maltoni G, Vaira B, et al. Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990s: an 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr. 2008; 46:612–4.

23. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012; 54:136–60.

24. Ludvigsson JF, Neovius M, Hammarström L. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study. J Clin Immunol. 2014; 34:444–51.

25. Kakleas K, Karayianni C, Critselis E, Papathanasiou A, Petrou V, Fotinou A, et al. The prevalence and risk factors for coeliac disease among children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract. 2010; 90:202–8.

26. Cerruti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C. Younger age at onset and sex predict coeliac disease in children and adolescents with type 1 diabetes. Diabetes Care. 2004; 27:1294–8.

27. Kakleas K, Kostaki M, Critselis E, Karayianni C, Giannaki M, Anyfantakis K, et al. Gastric autoimmunity in children and adolescents with type 1 diabetes: a prospective study. Horm Res Paediatr. 2012; 77:121–6.

28. Frohlich-Reiterer EE, Huber J, Katz H, Suppan E, Obermayer-Pietsch B, Deutschmann A, et al. Do children and adolescents with type 1 diabetes mellitus have a higher frequency of parietal cell antibodies than healthy controls? J PGN. 2011; 52:558–62.

29. De Block CE, De Leeuw IH, Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab. 1999; 84:4062–7.

30. Conti L, Annibale B, Lahner E. Autoimmune gastritis and gastric microbiota. Microorganisms. 2020; 8:1827.

31. Fröhlich-Reiterer EE, Huber J, Katz H, Suppan E, Obermayer-Pietsch B, Deutschmann A, et al. Do children and adolescents with type 1 diabetes mellitus have a higher frequency of parietal cell antibodies than healthy controls? J Pediatr Gastroenterol Nutr. 2011; 52:558–62.

32. De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, et al. Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus. Aliment Pharmacol Ther. 2002; 16:281–9.

33. Karavanaki K, Kakleas K, Paschali E, Kefalas N, Konstantopoulos I, Petrou V, et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res. 2009; 71:201–6.

34. Esteban M, Baxter AG. Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes. Clin Exp Immunol. 2001; 126:184–6.

35. Kakleas K, Basatemur E, Karavanaki K. Association between severity of diabetic ketoacidosis at diagnosis and multiple autoimmunity in children with type 1 diabetes mellitus: a study from a Greek Tertiary Centre. Can J Diabetes. 2021; 45:33–8.e2.

36. Krzewska A, Ben-Skowronek I. Effect of associated autoimmune diseases on type 1 diabetes mellitus incidence and metabolic control in children and adolescents. Biomed Res Int. 2016; 2016:6219730.

37. Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, Holl RW, et al. Other complications and associated conditions with diabetes in children and adolescents. Pediatr Diabetes. 2009; 10 Suppl 12:204–10.

38. Rogers MAM, Wei MY, Kim C, Lee JM. Sex differences in autoimmune multimorbidity in type 1 diabetes mellitus and the risk of cardiovascular and renal disease: a longitudinal study in the United States, 2001-2017. J Womens Health (Larchmt). 2020; 29:511–9.

39. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004; 350:2068–79.